Discoveries beyond BRCA1/2: Multigene testing in an Asian multi-ethnic cohort suspected of hereditary breast cancer syndrome in the real world

by Ow, S.G.W., Ong, P.Y., Lee, S.-C.
Published 2021

Inadequate family history assessment by oncologists is an important physician barrier to referral for hereditary breast cancer evaluation

by Ow, S.G.W., Yong, Y.F.L., Chieng, W.S., Phyu, P.S., Lee, S.-C.
Published 2014

Clinical genetic testing outcome with multi-gene panel in Asian patients with multiple primary cancers

by Chan, G.H.J, Ong, P.Y, Low, J.J.H, Kong, H.L, Ow, S.G.W, Tan, D.S.P, Lim, Y.W, Lim, S.E, Lee, S.-C
Published 2020

Impact of deviation from guideline recommended treatment on breast cancer survival in Asia

by Ho, P.J., Ow, S.G.W., Sim, Y., Liu, J., Lim, S.H., Tan, E.Y., Tan, S.-M., Lee, S.C., Tan, V.K.-M., Yap, Y.-S., Chay, W.Y., Tan, B.K.T., Wong, F.Y., Li, J., Hartman, M.
Published 2021

A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours

by Ang, Y.L.E., Ho, G.F., Soo, R.A., Sundar, R., Tan, S.H., Yong, W.P., Ow, S.G.W., Lim, J.S.J., Chong, W.Q., Soe, P.P., Tai, B.C., Wang, L., Goh, B.C., Lee, S.-C.
Published 2021

Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer

by Lim, JSJ, Wong, ALA, Ow, SGW, Ngoi, NYL, Chan, GHJ, Ang, YLE, Chong, WQ, Lim, SE, Lim, YW, Lee, M, Choo, JRE, Tan, HL, Yong, WP, Soo, RA, Tan, DSP, Chee, CE, Sundar, R, Yadav, K, Jain, S, Wang, L, Tai, BC, Goh, BC, Lee, SC
Published 2023

Limb hypothermia for preventing paclitaxel-induced peripheral neuropathy in breast cancer patients: A pilot study

by Sundar, R, Bandla, A, Tan, S.S.H, Liao, L.-D, Kumarakulasinghe, N.B, Jeyasekharan, A.D, Ow, S.G.W, Ho, J, Tan, D.S.P, Lim, J.S.J, Vijayan, J, Therimadasamy, A.K, Hairom, Z, Ang, E, Ang, S, Thakor, N.V, Lee, S.-C, Wilder-Smith, E.P.V
Published 2020

Low Levels of NDRG1 in nerve tissue are predictive of severe paclitaxel-induced neuropathy

by Sundar R., Jeyasekharan A.D., Pang B., Soong R.C.T., Kumarakulasinghe N.B., Ow S.G.W., Ho J., Lim J.S.J., Tan D.S.P., Wilder-Smith E.P.V., Bandla A., Tan S.S.H., Asuncion B.R., Fazreen Z., Hoppe M.M., Putti T.C., Poh L.M., Goh B.C., Lee S.-C.
Published 2018

Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer

by Wong A.L.A., Sundar R., Wang T.-T., Ng T.-C., Zhang B., Tan S.-H., Soh T.I.P., Pang A.S.L., Tan C.-S., Ow S.G.W., Wang L., Mogro J., Ho J., Jeyasekharan A.D., Huang Y., Thng C.-H., Chan C.-W., Hartman M., Iau P., Buhari S.A., Goh B.-C., Lee S.-C.
Published 2020